Abstract P2-08-02: Interaction of PIK3CA mutation subclasses with response to preoperative treatment with the PI3K inhibitor pictilisib in patients with estrogen receptor-positive breast cancer

Journal article

Peer reviewed

P Schmid, S Pinder, D Wheatley, C Zummit, E J Macaskill, J Hu, R Price, N Bundred, S Hadad, A Shia, …

Cancer research (Chicago, Ill.), Vol.79(4 Supplement), pp.P2-P2-08-02

2019-02-15

Metrics

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis; 1.25.803 mTOR
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Abstract P2-08-02: Interaction of PIK3CA mutation subclasses with response to preoperative treatment with the PI3K inhibitor pictilisib in patients with estrogen receptor-positive breast cancer
Creators: P Schmid
S Pinder
D Wheatley
C Zummit
E J Macaskill
J Hu
R Price
N Bundred
S Hadad
A Shia
S-J Sarker
L Lim
K Mousa
C O'Brien
T R Wilson
M R Lackner
S Gendreau
P Gazinska
D Korbie
M Trau
P Mainwaring
A Thompson
A Purushotham
Publication Details: Cancer research (Chicago, Ill.), Vol.79(4 Supplement), pp.P2-P2-08-02
Academic Unit: Miller School of Medicine; UMMG Department of Public Health Sciences Research
Language: English
Resource Type: Journal article
Record Identifier: 991031598490702976